- Adams, K. F. Jr. (2004).Pathophysiologic role of the renin-angiotensin- aldosterone and sympathetic nervous systems in heart failure. Am .J .Health-Syst. Pharm., 61(Suppl): S4–S13.
- Arsenault, W. G., Boothe, D. M., Gordon, S. G., Miller, M.W., Chalkley, J. R. and Petrikovics, I. (2005).Pharmacokinetics of carvedilol after intravenous and oral administration in conscious healthy dogs.Am. J.Vet.Res., 66: 2172-2176.
- Boswood, A., Dukes-McEwan, J., Loureiro, J., James, R. A., Martin, M., Stafford-Johnson, M., Smith, P., Little, C. and Attree, S. (2008).The diagnosis accuracy of different natriuretic peptides in the investigation of canine cardiac disease. J. Sm. Anim.Pract., 49:26-32.
- Crivellente. F., Tontodanati, M., Fasdelli, N., Casartelli, A., Dorigatti, R., Faustinelli, I. and Cristofori, P. (2011). NT-proBNP as a biomarker for assessment of a potential cardiovascular drug induced liability in beagle dogs. Cell. Biol.Toxicol., 27: 425-438.
- Dandona, P., Ghanim, H. and Brooks, D. P. (2007).Antioxidant activity of carvedilol in cardiovascular disease. J. Hypertens., 25: 731–741. Das, J.S., Ravikanth, V.V. and Sujatha, M. (2010). Nitric Oxide as a major risk factor for oxidative stress in coronary artery disease: a preliminary Investigation. Sci. and Cult., 76:174-175.
- Dukes-McEwan, J., Borgarelli, M., Tidholm, A., Vollmar, A. C. and Haggstrom, J. (2003). Proposed guidelines for the diagnosis of canine idiopathic dilated cardiomyopathy. J. Vet. Cardiol., 5: 7-19.
- Eichhorn, E. J. and Bristow, M. R. (1997). Practical guidelines for initiation of beta-adrenergic blockade in patients with chronic heart failure. Am. J. Cardiol., 79: 794-798.
- Gordon, S.G., Arsenault, W. G., Longnecker, M., Boothe, D. M., Miller M. W. and Chalkley, J. (2006). Pharmacodynamics of carvedilol in conscious, healthy dogs. J. Vet.Intern. Med., 20:297–304.
- Gugjoo, M. B., Saxena, A. C., Hoque, M. and Zama, M. M. S. (2014). M-mode echocardiographic study in dogs. Afr. J. Agric. Res., 9:387-396.
- Hall, S. A., Cigarroa, C. G., Marcoux, L., Risser, R. C., Grayburn, P.A. and Eichhorn, E. J (1995).Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade. J. Am. Coll. Cardiol., 25: 1154–1161.
- Karlapudi, S. K., Srikala, D. and Rao, D.S.T. (2012). Hypothyroidism - A cause for dilated cardiomyopathy in dogs; four year study (2008-2011). Vet.World ., 5: 742-747.
- Kumar, K. S., Nagaraj, P., Kumar, V.V.V.A. and Rao, D. S. T. (2010). Hypertrophic cardiomyopathy in 12 dogs (2004-2008): first report in India. Veterinarski Archiv., 80: 491-498.
- Lechat, P., Packer, M., Chalon, S., Cucherat, M., Arab, T. and Biossel, J.P. (1998) .Clinical effects of â-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials. Circ.,98:1184–1191.
- Marcondes-Santos, M., Tarasoutchi, F., Antonio, P., Mansur, A. P. And Strunz, C. M. C. (2007). Effects of carvedilol treatment in dogs with chronic mitral valvular disease. J. Vet. Intern Med., 21:996–1001.
- Martin, M.W., Stafford, M.J., Strehlau, G. and King, J.N. (2010). Canine dilated cardiomyopathy: a retrospective study of prognostic findings in 367 clinical cases. J. Sm. Anim.Pract., 51:428-436.
- Meurs, K.M., Miller, M.W. and Wright, N.A. (2001). Clinical features of dilated cardiomyopathy in Great Danes and results of pedigree analysis: 17 cases (1990-2000). J. Am. Vet. Med. Assoc.,5: 729-732.
- Neglia, D., De Maria, R., Masi, S., Gallopin, M., Pisani, P., Pardini, S., Gavazzi, A., L’Abbate, A. and Parodi, O. (2007).Effects of long term treatment with carvedilol on myocardial blood flow in idiopathic dilated cardiomyopathy. Heart., 93:808–813.
- Nichols, A. J., Gellai, M. and Ruffolo, R.R.J. (1991).Studies on the mechanism of arterial vasodilation produced by the novel antihypertensive agent, carvedilol. Fundamental & Clinical Pharmacology., 5:25-38.
- Noszczyk-Nowak, A. (2011). NT-pro-BNP and troponin I as predictors of mortality in dogs with heart failure.Pol. J. Vet. Sci., 14: 551-556.
- O’Grady, M.R., Minors, S.L., O’Sullivan, M.L. and Horne, R. (2008). Effect of pimobendan on case fatality rate in doberman Pinschers with congestive heart failure caused by dilated cardiomyopathy. J. Vet. Intern. Med., 22:897–904.
- Opasich, C., De Feo, S. and Cioffi,G. (2005). Does atrial fibrillation in elderly patients with chronic heart failure limit the efficacy of carvedilol? Suggestions from an observational study. Ital. Heart J., 6:323-327.
- Oyama, M. A., Sisson, D.D and Solter, F. (2007a).Prospective screening for occult cardiomyopathy in dogs by measurement of plasma atrial natriuretic peptide, B-type natriuretic peptide, and cardiac troponin-I concentrations. Am. J. Vet. Res.,68: 42–47.
- Oyama, M.A., Sisson, D.D., Prosek, R., Bulmer, B.J., Luethy, M.W. and Fuentes, V. L. (2007b). Carvedilol in Dogs with Dilated Cardiomyopathy.J. Vet. Intern. Med., 21:1272–1279.
- Packer, M., Bristow, M.R., Cohn, J.N., Colucci, W.S., Fowler, M.B., Gilbert, E.M. and Shusterman, N.H. (1996). The Effect of carvedilol on morbidity and mortality in Patients with chronic heart failure. N. Engl. J. Med., 334:1349-1355.
- Palazzuoli, A., Quatrini, I. and Vecchiato, L. (2005). Left ventricular diastolic function improvement by carvedilol therapy in advanced heart failure. J. CardiovascPharmacol., 45:563-568.
- Pandian, J. S. (2005): Clinical and ultrasonographic investigation of ascites in dogs. M.V.Sc. thesis. Kerala Agriculture University, Thrissur, India.
- Pereira, L., Larsson, M.H.M.A., Leomil Neto, M and Brito, F.S. (2004). Cardiomyopathy in the English Cocker Spaniel: clinical, electrocardiographic, radiographic and echocardiographic aspect. Ciencia Rural., 34:419-424.
- Pitt, B., Zannad, F., Reme, W.J., Cody, R., Castaigne, A., Perez, A., Palensky, J. and Wittes, J. (1999). For the randomized aldactone evaluation study investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N. Engl. J. Med., 341: 709–717.
- Poole-Wilson, P.A., Swedberg, K., Cleland, J.G.F., Lenarda, A.D., Hanrath, P., Komajda, et al., (2003). Comparison of carvedilol or metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol or Metoprolol European Trial (COMET): randomized controlled trial. Lancet., 362: 7–13.
- Pouchelon, J. L., Martignoni, L., King, J .N., Berres, M. (1999). The effect of benazepril on survival times and clinical signs of dogs with congestive heart failure: Results of a multicenter, prospective, randomized, double-blinded, placebo-controlled, long- term clinical trial. J. Vet.Cardiol., 1: 7-18.
- Rossig, L., Haendeler, J., Mallat, Z., Hugel, B., Freyssinet, J.M., Tedgui, A., Dimmeler, S. and Zeiher, A.M. (2000).Congestive heart failure induces endothelial cell apoptosis: protective role of carvedilol. J. Am. Coll. Cardiol., 36:2081–2089.
- Sastry, K.V.H., Moudgal, R. P., Mohan, J., Tyagi, J.S and Rao, G.S. (2002). Spectrophotometric Determination of Serum Nitrite and Nitrate by Copper–Cadmium Alloy. Anal.Biochem., 306:79–82.
- Sesh, P.S.L., Venkatesan, P., Jeyaraja, K., Chandrasekar., M and Pandiyan, V. (2015). Xanthine oxidase as a biochemical marker of dilated cardiomyopathy in dogs. Indian J. Anim. Res., 49: 187-190.
- Snedecor, W.G. and Cochran, G.W. (1994). Statistical Methods. 8thed. lowa State University Press, Ames.
- Soares, E.C., Pereira, G.G., Petrus, L.C., Leomil Neto, M., Yamaki, F. L. and Larsson, M.H.M.A. (2010). Survival and echocardiographic evaluation of dogs with idiopathic dilated cardiomyopathy treated with carvedilol. Braz. J. Vet. Anim. Sci., 62: 555-563.
- Summerfield, N.J., Boswood, A., O’Grady, M.R., Gordon, S.G., Dukes-McEwan, J., Oyama, M.A., et al., (2012). Efficacy of Pimobendan in the prevention of congestive heart failure or sudden death in Doberman Pinschers with preclinical dilated cardiomyopathy (The PROTECT Study). J. Vet. Intern. Med.,26:1337–1349.
- Takaya, J., Ikemoto, Y., Teraguchi, M., Nogi, S. and Kobayashi, Y. (2000): Plasma nitric oxide products correlate with cardiac index of congenital heart disease. Pediatr Cardiol., 21:378–381.
- Thomas, W.P., Gaber, C.E. and Jacobs, G.J. (1993).Recommendations for standards in transthoracic two-dimesional echocardiography in the dog and cat. J. Vet. Intern. Med., 7: 247:252.
- Tidholm, A. (2006). Survival in dogs with dilated cardiomyopathy and congestive heart failure treated with digoxin, furosemide and propranolol: A retrospective study of 62 dogs. J. Vet. Cardiol., 8:41-47.
- Tidholm, A. and Jonsson, L. (2005): Histologic characterization of canine dilated cardiomyopathy. Vet.Pathol., 42:1–8.
- Tilley, L.P. (1985): Analysis of P-QRS-T deflections. In: Essentials of Canine and Feline Electrocardiogrphy. 2nd ed., Lea and Febiger, Philadelphia, USA, pp. 57-97.
- Wali, R.K., Iyenger, M., Beck, G.J., Chartyan, D.M., Chonchol, M., Lukas, M.A., Cooper, C., et al., (2011). Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease. Circ: Heart Fail., 4: 18-26.
- Wiersma, A.C., Leegwater, P.A.J., Van Oost, B.A., Ollier, W.E. and Dukes-McEwan, J. (2007): Canine candidate gene for dilated cardiomyopathy: annotation of and polymorphic markers for 14 genes. BMC Vet. Res., 3: 28-35.
Submitted Date : 20-01-2017
Accepted Date : 27-12-2017
First Online: